pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

4,878 catalysts · 4,876 phase readout · 2,347 8k filing · 286 earnings · 275 pdufa · 166 phase 2 completion · 71 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-20: 0 catalysts2026-07-21: 0 catalysts2026-07-22: 0 catalysts2026-07-23: 0 catalysts2026-07-24: 9 catalysts2026-07-25: 0 catalysts2026-07-26: 0 catalysts2026-07-27: 2 catalysts2026-07-28: 4 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: phase readout×type: recall×type: approval×clear all
type
  • phase readout4,876
  • 8k filing2,347
  • earnings286
  • pdufa275
  • phase 2 completion166
  • phase 1 completion71
phase 2 initiation
54
  • phase 1 initiation39
  • phase 1 2 completion33
  • phase 0 trial completion23
  • therapy area

    no tagged catalysts yet

    Date TBD

    50
    ›COMPLETEDphase readoutNCT05446194: Vestibulopathy, Imbalance, and Gait Disturbances in Parkinson Disease

    Sponsor: University of Michigan. Phase: NA. Conditions: Parkinson Disease

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06656494: ICP-248 in Combination With Azacitidine for the Treatment in Patients With Myeloid Malignancies

    Sponsor: Beijing InnoCare Pharma Tech Co., Ltd.. Phase: PHASE1. Conditions: Acute Myelogenous Leukemia, Myelodysplastic Syndromes (MDS)

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07622394: Structured Cardio-Oncology Rehabilitation for Cardiovascular Outcomes in Cancer Survivors

    Sponsor: Xinjiang Medical University. Phase: NA. Conditions: Cancer Therapy-Related Cardiac Dysfunction, Cardio-oncology, Cancer Survivorship, Cardiovascular Risk, Heart Failure

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT03674229: Patients Navigators in Facilitating Weight Management in Obese Participants

    Sponsor: M.D. Anderson Cancer Center. Phase: NA. Conditions: Health Status Unknown, Obesity

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT06055231: PK/PD of Vaping THC-containing Liquids vs. Smoked Cannabis

    Sponsor: Roswell Park Cancer Institute. Phase: PHASE1. Conditions: Cigarette Smoking-Related Carcinoma

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07480031: Determination of the Optimal Inspiratory Pressure to Decrease Incidence of Gastric Insufflation With Adequate Ventilation During Facemask Ventilation in Morbidly Obese Patients

    Sponsor: Benha University. Phase: NA. Conditions: Gastric Insufflation

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05819931: Breathing With Amyotrophic Lateral Sclerosis

    Sponsor: University Hospital, Toulouse. Phase: NA. Conditions: Amyotrophic Lateral Sclerosis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06954402: Resilience Among Individuals With Opioid Use Disorder

    Sponsor: Johns Hopkins University. Phase: NA. Conditions: Opioid Use Disorder

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04627753: Study of Lenalidomide/Rituximab Maintenance for Transplantation Ineligible Patients With PCNSL.

    Sponsor: Kim, Seok Jin. Phase: PHASE2. Conditions: Primary CNS Lymphoma

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07597902: SARS-CoV-2 and Herpesvirus Inhibition for Ending Long COVID Dysfunction

    Sponsor: Icahn School of Medicine at Mount Sinai. Phase: PHASE2. Conditions: Post-acute Sequelae of COVID-19, Long COVID

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07517653: Neoadjuvant SHR-1701 Plus Famitinib With Response-guided Adjuvant Therapy in Resectable Mucosal Melanoma

    Sponsor: Shanghai Zhongshan Hospital. Phase: PHASE2. Conditions: Melanoma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05504837: A Study Assessing KB407 for the Treatment of Cystic Fibrosis

    Sponsor: Krystal Biotech, Inc.. Phase: PHASE1. Conditions: Cystic Fibrosis

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT00953537: Predicting Response to Capecitabine in Women With Metastatic Breast Cancer

    Sponsor: Centre Antoine Lacassagne. Phase: NA. Conditions: Breast Cancer

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07557537: A Phase 1 Study of KHN707 Tablets in Healthy Participants

    Sponsor: Chengdu Kanghong Pharmaceutical Group Co., Ltd.. Phase: PHASE1. Conditions: Healthy Adult Participants

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07622095: Validation of the French Version of the New Mobility Score (NMS)

    Sponsor: Hospices Civils de Lyon. Phase: . Conditions: Hip Fractures, Mobility Limitation, Independence, Autonomy

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07182877: Comparison of Dwell Time of Open Versus Closed Type Peripheral Intravenous Cannula

    Sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh. Phase: NA. Conditions: Thrombophlebitis

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07063277: Comparison of Oxygen Reserve Index and Spirometry in Predicting Respiratory Complications After Coronary Artery Bypass Surgery

    Sponsor: Ankara Bilkent Sehir Hastanesi. Phase: NA. Conditions: Coronary Arterial Disease (CAD), Coronary Artery Bypass Graft (CABG), Postoperative Pulmonary Complication

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07316777: Saudi CABG Audit and Registry

    Sponsor: King Faisal Specialist Hospital & Research Center. Phase: . Conditions: Coronary Artery Bypass Graft (CABG)

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07407257: SBRT for Liver Tumors, Liver Metastases, and Pancreatic Tumors

    Sponsor: Institute of Oncology Ljubljana. Phase: NA. Conditions: Liver Neoplasms, Liver Metastases, Pancreatic Neoplasms

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT07642401: Large-scale Models of Esophageal Cancer and Related Research

    Sponsor: The First Affiliated Hospital of Henan University of Science and Technology. Phase: . Conditions: Esophageal Cancer

    full page →ctgov ↗
    ›SUSPENDEDphase readoutNCT07173101: Clinical Investigation of the Effects of Semiconductor Embedded Therapeutic Garments on Cancer-related Cognitive Impairment in Breast and Gynecological Cancer Patients

    Sponsor: University of Utah. Phase: PHASE2. Conditions: Breast Cancer, Gynecologic Cancer, Cancer-related Cognitive Difficulties

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06787612: Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer

    Sponsor: Regeneron Pharmaceuticals. Phase: PHASE2. Conditions: Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06568601: Pharmacogenomic Informed Statin Prescribing

    Sponsor: VA Office of Research and Development. Phase: NA. Conditions: Hypercholesterolemia

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06217601: Impact Evaluation of the Digital Connect Project for Homebound Older Adults

    Sponsor: The University of Hong Kong. Phase: NA. Conditions: Aging Well

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03206801: Urine CXCL10 Monitoring Trial in Kidney Transplant

    Sponsor: University of Manitoba. Phase: PHASE2. Conditions: Kidney Transplant; Complications, Rejection of Renal Transplant

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07147101: Different First-line Immunotherapy for Advancer Hepatocellular Carcinoma: A Prospective Observational Study on Efficacy and Immune Microenvironment

    Sponsor: Fudan University. Phase: . Conditions: Advanced Hepatocellular Carcinoma (HCC)

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05513001: An Extension Study of Long-term Efficacy, Safety and Tolerability of Remibrutinib in Chronic Spontaneous Urticaria Patients Who Completed Preceding Studies With Remibrutinib

    Sponsor: Novartis Pharmaceuticals. Phase: PHASE3. Conditions: Chronic Spontaneous Urticaria

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07410481: Trial of Acceptance and Mindfulness-based Exposure Therapy (AMBET) and Present Centered Therapy (PCT)

    Sponsor: Columbia University. Phase: NA. Conditions: PTSD - Post Traumatic Stress Disorder, Cardiac Arrest (CA)

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07471581: Patient Satisfaction Study at AOU Maggiore Della Carità (SCORE)

    Sponsor: Università degli Studi del Piemonte Orientale Amedeo Avogadro. Phase: . Conditions: Patient Satisfaction, Nursing, Nursing Care, Patient-Centered Care, Cross-Sectional Studies

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06437119: The Antagonistic Effect of Composite Polyphenols on Health Damage Caused by Environmental Pollutants

    Sponsor: Fudan University. Phase: NA. Conditions: Intestinal Functional Disorder, Inflammation

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03108430: Study of Risk Factors for Developing Inhalation Pneumonia After Inhalation

    Sponsor: Centre Hospitalier Universitaire, Amiens. Phase: . Conditions: Inhalation Pneumonia, Risk Factor

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT04433728: Life With Phenylketonuria. Adult Neurological Outcome of PCU Screened Patients From 1971 to 2002.

    Sponsor: University Hospital, Lille. Phase: . Conditions: Phenylketonurias

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT06648928: Clinician Supported Mobile App to Reduce Mental Health Symptoms Among World Trade Center Responders in Florida

    Sponsor: Florida International University. Phase: NA. Conditions: PTSD Symptoms, Anxiety Symptoms, Depression Symptoms, Sleep Disturbance

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07529067: Effect of the Marmet Technique on Breastfeeding Problems and Breastfeeding Self-Efficacy in Postpartum Women

    Sponsor: Medipol University. Phase: NA. Conditions: Breastfeeding Problems Assessment, Breastfeeding Self-Efficacy

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07230067: Sepsis-associated Thrombocytopenia and Platelet Transfusion (STAPT)

    Sponsor: Nanfang Hospital, Southern Medical University. Phase: . Conditions: Sepsis, Sepsis and Coagulopathy

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT06624800: The Efficacy and Safety of Shoulder Chuna on in Patients With Shoulder Pain Caused by Traffic Accidents

    Sponsor: Jaseng Medical Foundation. Phase: NA. Conditions: Acute Shoulder Pain

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06013007: Joint Inflation With Nominal-pressure and Stability Approach in DES Optimization

    Sponsor: Zunyi Medical College. Phase: NA. Conditions: Acute Coronary Syndrome, De Novo Stenosis

    full page →ctgov ↗
    ›SUSPENDEDphase readoutNCT06739707: Subcutaneously Administered MD-18 for the Treatment of Obesity and Diabetes

    Sponsor: Cohen Global, Ltd.. Phase: PHASE1. Conditions: Healthy Volunteer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06025292: Effects of Lean Pork Loin Intake on Protein Homeostasis and Glucose Regulation in Prediabetic Adults

    Sponsor: University of Arkansas. Phase: NA. Conditions: Hyperglycaemia (Non Diabetic), Prediabetes

    full page →ctgov ↗
    ›AVAILABLEphase readoutNCT05041036: Individual Patient Compassionate Use of Nirogacestat

    Sponsor: SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany. Phase: . Conditions: Desmoid Tumor, NOTCH Gene Mutation Positive Tumors

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03012971: Dexmedetomidine Supplemented Analgesia and Long-term Survival After Cancer Surgery

    Sponsor: Peking University First Hospital. Phase: NA. Conditions: Elderly, Surgery, Analgesia, Dexmedetomidine, Long-term Outcome

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07444671: Impact of Time-restricted Eating on Sleep, Glucose and Insulin Sensitivity

    Sponsor: Colorado State University. Phase: NA. Conditions: Time Restricted Eating

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07243171: A Phase Ib/IIa Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Ecnoglutide Tablets in Chinese Participants With Overweight or Obesity

    Sponsor: Hangzhou Sciwind Biosciences Co., Ltd.. Phase: PHASE1. Conditions: Overweight and/or Obesity, Weight Management

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07616271: Study on the Effect of Oral Diammonium Glycyrrhizinate in Attenuating Toxicity and Enhancing Efficacy of CAR-T Cell Therapy

    Sponsor: Tongji Hospital. Phase: PHASE2. Conditions: Patients With Large B-cell Lymphoma Receiving CAR-T Cell Therapy

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07352644: Factors Affecting Attachment Loss in Clear Aligner Treatment

    Sponsor: Bezmialem Vakif University. Phase: NA. Conditions: Malocclusion, Crowded Teeth, Attachment

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04145141: National Translational Science Network of Precision-based Immunotherapy for Primary Liver Cancer

    Sponsor: National Cancer Institute (NCI). Phase: . Conditions: Hepatocellular Carcinoma, Liver Cancer, Cholangiocarcinoma

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT06943573: Psilocybin-Assisted Therapy for Treatment-Resistant Depression in Bipolar II Disorder

    Sponsor: Lakshmi N Yatham. Phase: PHASE3. Conditions: Bipolar II Depression

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07455669: Effects of Microgalvanic Current on Body Satisfaction and Quality of Life in Women With Striae Alba

    Sponsor: Federal University of the Valleys of Jequitinhonha and Mucuri. Phase: NA. Conditions: White Stretch Marks (Striae Albae)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04248283: Adjustable Continence Therapy (ACT) for the Treatment of Female SUI

    Sponsor: Uromedica. Phase: NA. Conditions: Urinary Incontinence, Urinary Incontinence,Stress

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06708754: Impact of Photobiomodulation (PBM) on Biomarkers of Radiation Lymphedema and Fibrosis in Head and Neck Cancer Patients

    Sponsor: NYU Langone Health. Phase: NA. Conditions: Radiation Lymphedema, Radiation Fibrosis, Head and Neck Cancer

    full page →ctgov ↗
    ← prev
    page 68 of 98
    next →